+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Vertebroplasty Needle Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 182 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5820252

VCFs are the most common fracture in patients with osteoporosis, affecting about 750,000 people annually

The Global Vertebroplasty Needles Market is estimated to be USD 932.44 Mn in 2023 and is expected to reach USD 1391.76 Mn by 2028 growing at a CAGR of 8.34%.

Vertebroplasty is a treatment that injects cement into a cracked or broken spinal bone to help relieve pain. Spinal bones are called vertebrae. Vertebroplasty is often used to treat a type of injury called a compression fracture. These injuries are usually caused by osteoporosis, a condition that weakens bone.

The market for vertebroplasty needles has expanded significantly due to the rising incidence of spine disorders like osteoporosis, vertebral fractures, and spinal malignancies. The prevalence of spine disorders is predicted to increase as the population ages. According to a survey by the National Osteoporosis Foundation, 54 million Americans are expected to have osteoporosis or low bone mass. The demand for vertebroplasty procedures is therefore anticipated to rise. Technology advancements and the creation of new needle materials for vertebroplasty have further increased the procedure's safety and effectiveness. These improvements have improved patient satisfaction and made the surgery more accessible.

However, the availability of alternative treatments may limit the market growth for vertebroplasty needles. For instance, kyphoplasty is similar to vertebroplasty but uses a balloon to provide room for bone cement. In some circumstances, this method may be preferred over vertebroplasty since it gives the patient better control over the injection and lowers the possibility of cement leakage. As a result, kyphoplasty may be preferred by some medical professionals over vertebroplasty, which lowers the demand for vertebroplasty needles.

Technological advancements in healthcare are creating significant opportunities for vertebroplasty needles used in the minimally invasive surgical procedure known as vertebroplasty. The advancement of advanced imaging methods is one way that technology improvements are opening doors for vertebroplasty needles. X-rays were once used to direct the placement of the needles during vertebroplasty procedures. However, it is now possible to obtain considerably more detailed images of the spine because of the advent of more precise imaging techniques, like CT and MRI scans. This makes it possible to put the needles considerably more accurately, which could increase the procedure's overall effectiveness. Furthermore, the development of new designs and materials for needles aid in to increase in market growth. For Instance, some vertebroplasty needles now use polymers or other materials that are less likely to cause infection or bleeding.
  • The market for vertebroplasty needles and related items may suffer due to individuals being deterred from seeking treatment for spine fractures because of high treatment costs. There may be a drop in demand for vertebroplasty needles as a result of patients choosing alternate treatments or postponing their treatments altogether.

Market Segmentations

  • The Global Vertebroplasty Needle Market is segmented based on Distribution Channel, Procedure, End-User, and Geography.
  • By Distribution Channel, the market is classified into Hospital Pharmacies, Private Clinics, Retail Pharmacies, and Drug Stores.
  • Hospital Pharmacies have the largest market share among all as most of the procedures performed in hospitals and the requirement of doctor’s consultation for needle.
  • By Procedure, the market is classified into Directional Vertebroplasty Needles and Straight Vertebroplasty Needles.
  • Straight Vertebroplasty Needles segment has the largest market share.
  • By End-User, the market is classified into Hospitals and Ambulatory Surgical Centers.
  • Hospitals’ end-use segments have the highest market share due to superior infrastructure facilities in developed nations, the hospital sector is more promising there. Also, the market for vertebroplasty needles is expanding since vertebral compression fractures cause about 70,000 hospitalizations each year in the United States.
  • By Geography, the market is classified into the Americas, Europe, Middle East & Africa, and Asia-Pacific.
  • America has the largest market share since the pricing pressure is low due to the presence of major companies and distributors in the region. Furthermore, this region is witnessing an increase in osteoporosis prevalence along with huge demand for minimally invasive surgery to treat VCFs.

Recent Development

  • For the treatment of spinal vertebrae fractures and other orthopedic procedures, SetBone created a unique bone cement. The company recently closed a USD 1.6 million oversubscribed funding round - January 2022.
  • Hyprevention, a French company, raised USD 4.5 million for vertebral implant development in the United States to roll out its STRUTPLASTY platform in the country - April 2022.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are, ATEC Spine, Inc., DJO LLC, IZI Medical Products, Stryker Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Vertebroplasty Needles Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Vertebroplasty Needles Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Vertebroplasty Needles Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
  • Excel data sheet for the market size will also be provided with the report.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
  • The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
  • Market segmentation
  • Competitive Analysis: Comparative analysis of competitor
  • Historical, current, and projected size of the market based on value and volume
  • Market size of the US states
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Increasing Prevalence of Spine Disorder
4.2.2 Increasing Funding for Research for Medical Treatment
4.3 Restraints
4.3.1 Alternative Treatments Available for Vertebral Fractures
4.4 Opportunities
4.4.1 Technological Advancements in Healthcare Sector
4.5 Challenges
4.5.1 High Cost of Treatment
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Vertebroplasty Needles Market, By Distribution Channel
6.1 Introduction
6.2 Hospital Pharmacies
6.3 Private Clinics
6.4 Retail Pharmacies and Drug Stores
6.5 E-Commerce
7 Global Vertebroplasty Needles Market, By Procedure
7.1 Introduction
7.2 Directional Vertebroplasty Needles
7.3 Straight Vertebroplasty Needles
8 Global Vertebroplasty Needles Market, By End-User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers
9 Americas' Vertebroplasty Needles Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe's Vertebroplasty Needles Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Ireland
10.10 Luxemburg
10.11 Netherlands
10.12 Norway
10.13 Poland
10.14 Russia
10.15 Spain
10.16 Sweden
10.17 Switzerland
10.18 United Kingdom
10.19 Rest of Europe
11 Middle East and Africa's Vertebroplasty Needles Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Nigeria
11.6 Saudi Arabia
11.7 South Africa
11.8 United Arab Emirates
11.9 Rest of MEA
12 APAC's Vertebroplasty Needles Market
12.1 Introduction
12.2 Australia+
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
14 Company Profiles
14.1 ATEC Spine, Inc.
14.1.1 Company Overview
14.1.2 Company Snapshot
14.1.3 Product Overview
14.1.4 Business Overview
14.1.5 SWOT Analysis
14.1.6 Recent Development
14.2 Biopsybell S.R.L.
14.2.1 Company Overview
14.2.2 Company Snapshot
14.2.3 Product Overview
14.2.4 Business Overview
14.2.5 SWOT Analysis
14.2.6 Recent Development
14.3 DePuy Synthes
14.3.1 Company Overview
14.3.2 Company Snapshot
14.3.3 Product Overview
14.3.4 Business Overview
14.3.5 SWOT Analysis
14.3.6 Recent Development
14.4 DJO, LLC
14.4.1 Company Overview
14.4.2 Company Snapshot
14.4.3 Product Overview
14.4.4 Business Overview
14.4.5 SWOT Analysis
14.4.6 Recent Development
14.5 Global Medical, Inc.
14.5.1 Company Overview
14.5.2 Company Snapshot
14.5.3 Product Overview
14.5.4 Business Overview
14.5.5 SWOT Analysis
14.5.6 Recent Development
14.6 IZI Medical Products
14.6.1 Company Overview
14.6.2 Company Snapshot
14.6.3 Product Overview
14.6.4 Business Overview
14.6.5 SWOT Analysis
14.6.6 Recent Development
14.7 Laurane Medical LLC
14.7.1 Company Overview
14.7.2 Company Snapshot
14.7.3 Product Overview
14.7.4 Business Overview
14.7.5 SWOT Analysis
14.7.6 Recent Development
14.8 Medtronic PLC
14.8.1 Company Overview
14.8.2 Company Snapshot
14.8.3 Product Overview
14.8.4 Business Overview
14.8.5 SWOT Analysis
14.8.6 Recent Development
14.9 Merit Medical System, Inc.
14.9.1 Company Overview
14.9.2 Company Snapshot
14.9.3 Product Overview
14.9.4 Business Overview
14.9.5 SWOT Analysis
14.9.6 Recent Development
14.10 Moller Medical GmbH
14.10.1 Company Overview
14.10.2 Company Snapshot
14.10.3 Product Overview
14.10.4 Business Overview
14.10.5 SWOT Analysis
14.10.6 Recent Development
14.11 Osseon Technologies
14.11.1 Company Overview
14.11.2 Company Snapshot
14.11.3 Product Overview
14.11.4 Business Overview
14.11.5 SWOT Analysis
14.11.6 Recent Development
14.12 Rontis Pharmaceuticals
14.12.1 Company Overview
14.12.2 Company Snapshot
14.12.3 Product Overview
14.12.4 Business Overview
14.12.5 SWOT Analysis
14.12.6 Recent Development
14.13 Smith & Nephew PLC
14.13.1 Company Overview
14.13.2 Company Snapshot
14.13.3 Product Overview
14.13.4 Business Overview
14.13.5 SWOT Analysis
14.13.6 Recent Development
14.14 Spinal Elements, Inc.
14.14.1 Company Overview
14.14.2 Company Snapshot
14.14.3 Product Overview
14.14.4 Business Overview
14.14.5 SWOT Analysis
14.14.6 Recent Development
14.15 Stryker Corp.
14.15.1 Company Overview
14.15.2 Company Snapshot
14.15.3 Product Overview
14.15.4 Business Overview
14.15.5 SWOT Analysis
14.15.6 Recent Development
14.16 Suretech Medical Inc.
14.16.1 Company Overview
14.16.2 Company Snapshot
14.16.3 Product Overview
14.16.4 Business Overview
14.16.5 SWOT Analysis
14.16.6 Recent Development
14.17 Tecres S.p.A.
14.17.1 Company Overview
14.17.2 Company Snapshot
14.17.3 Product Overview
14.17.4 Business Overview
14.17.5 SWOT Analysis
14.17.6 Recent Development
14.18 Teknimed
14.18.1 Company Overview
14.18.2 Company Snapshot
14.18.3 Product Overview
14.18.4 Business Overview
14.18.5 SWOT Analysis
14.18.6 Recent Development
14.19 Zavation Medical Products, LLC
14.19.1 Company Overview
14.19.2 Company Snapshot
14.19.3 Product Overview
14.19.4 Business Overview
14.19.5 SWOT Analysis
14.19.6 Recent Development
14.20 Zimmer Biomet
14.20.1 Company Overview
14.20.2 Company Snapshot
14.20.3 Product Overview
14.20.4 Business Overview
14.20.5 SWOT Analysis
14.20.6 Recent Development
15 Appendix
15.1 Self-Assessment Form

Companies Mentioned

  • ATEC Spine, Inc.
  • Biopsybell S.R.L.
  • DePuy Synthes
  • DJO, LLC
  • Global Medical, Inc.
  • IZI Medical Products
  • Laurane Medical LLC
  • Medtronic PLC
  • Merit Medical System, Inc.
  • Moller Medical GmbH
  • Osseon Technologies
  • Rontis Pharmaceuticals
  • Smith & Nephew PLC
  • Spinal Elements, Inc.
  • Stryker Corp.
  • Suretech Medical Inc.
  • Tecres S.p.A.
  • Teknimed
  • Zavation Medical Products, LLC
  • Zimmer Biomet

Table Information